Showing 301-310 of 2351 results for "".
Managing Diaper Dermatitis
https://practicaldermatology.com/topics/pediatric/managing-diaper-dermatitis/20357/First-line treatment tips and a review of when to assess for an alternate diagnosis.Warts and All: A Treatment Update for Verruca Vulgaris
https://practicaldermatology.com/topics/general-topics/warts-and-all-a-treatment-update-for-verruca-vulgaris/21451/Body Dysmorphic Disorder Screening Tools for the Dermatologist: A Systematic Review
https://practicaldermatology.com/topics/general-topics/body-dysmorphic-disorder-screening-tools-for-the-dermatologist-a-systematic-review-s/21231/Update on Isotretinoin, Depression, and Suicide: Appropriate Monitoring is Key
https://practicaldermatology.com/topics/general-topics/update-on-isotretinoin-depression-and-suicide-appropriate-monitoring-is-key/21859/Data have failed to show a direct relationship between isotretinoin use and depression or suicide, but the cumulative evidence suggests patients with severe acne require careful monitoring.Pre-Treating Resectable Melanomas with PD-1 Inhibitors: An Emerging Strategy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pre-treating-resectable-melanomas-with-pd-1-inhibitors-an-emerging-strategy/20489/Pre-treatment with anti-PD1 agents may improve outcomes for some patients and provide prognostic clues.Advancements in Skin Protection and Skin Cancer Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advancements-in-skin-protection-and-skin-cancer-management/20720/Experts discuss some of the latest developments with an emphasis on implications for patient care.Pearls for Choosing and Initiating Psoriasis Therapy
https://practicaldermatology.com/topics/psoriasis/PD0309_18-php/22872/Members of the psoriasis panel at the 2009 South Beach Symposium last month offered insights on patient care.Practical Tips for Managing Hedgehog Pathway Inhibitor Side Effects
https://practicaldermatology.com/topics/practice-management/practical-tips-for-managing-hedgehog-pathway-inhibitor-side-effects/20774/AbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society anHow Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended surviv